Board of Directors
Chairman : Charles Lin
Director : Yung-Shun Wen
Director : Grand Spirit Investments Limited (Representative : Chen-Yu Fang)
Director : CDIB Capital Healthcare Ventures (Representative : Yi-Jiun Gau)
Independent Director : Shoei-Sheng Lee
Independent Director : Shu-Chin Liang
Independent Director : Su Fnag Yang
Mr. Lin received his BS from Department of Pharmacy of National Taiwan University and has over 40 years of experience in the pharmaceutical industry. When he was the Chairman of Lotus Pharmaceutical, he successfully led Lotus to be listed on the OTC market and transformed it into an international pharmaceutical company. In 2016, Mr. Lin founded Alar Pharmaceuticals Inc.. With many years of experience in pharmaceutical R&D, innovation and marketing, familiarity with corporate governance, and international outlook, he has been committed to lead Alar to become an international new pharmaceutical company.
Yung-Shun Wen Ph.D
Dr. Wen received his PhD in Chemistry from the National Taiwan University and has more than 20 years of experience in the pharmaceutical industry. When he was the director of R&D department in a well-known pharmaceutical company, he led the R&D team to break through technical barriers and bring the products to market in advanced countries such as Europe, America and Japan. With extensive experience in R&D resources utilization and team management, Dr. Wen aims to lead Alar to bring developing products into market and enhance the company’s overall value.
Director of Finance
Ms. Kang received her MBA from Texas A&M University, Commerce. She has more than 10 years of experience in financial management and had previously worked in famous listed companies in Taiwan and China.